Market Overview

UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Monsanto Company

Share:
Related MON
Can Monsanto Stop The 'Billion Dollar Pest'?
The Prospect Of The U.S. Blocking The Bayer-Monsanto Deal Can't Be Dismissed
The Vetr community has upgraded $MON to 3.5-Stars. (Vetr)

In a report published Wednesday, Canaccord Genuity reiterated its Buy rating on Monsanto Company (NYSE: MON), and raised its price target from $104.00 to $113.00.

Canaccord Genuity noted, “From an industry viewpoint, we continue to expect another record planting in the US this spring, followed by a further record planting in Latin America next fall, which should set up the company for a strong F2013 and a positive start to F2014. We believe Monsanto will be able to capitalize on these expected macro events more than its peers due to its yield leading products, both current and those in the pipeline, and the benefit that we should continue to see roll out in both North and South America throughout our forecast period. From a pipeline viewpoint, we see no equal when it relates to the level of product launches the company should be able to introduce both in the near and medium term. As a result, we believe the company's shares will continue to outperform its peers and the market in 2013.”

Monsanto Company closed on Tuesday at $98.45.

Latest Ratings for MON

DateFirmActionFromTo
Jun 2017SusquehannaDowngradesPositiveNeutral
Feb 2017RBC CapitalInitiates Coverage OnSector Perform
Nov 2016OTR GlobalUpgradesNegativeMixed

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Price Target Analyst Ratings

 

Related Articles (MON)

View Comments and Join the Discussion!